Chin J - Search Results

1

Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.

Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Bladou F, Mercado A, Levental M, Ghai S, Chang SD, Milot L, Patel C, Kassam Z, Moore C, Kasivisvanathan V, Loblaw A, Kebabdjian M, Earle CC, Pond GR, Haider MA. Klotz L, et al. Among authors: chin j. JAMA Oncol. 2021 Apr 1;7(4):534-542. doi: 10.1001/jamaoncol.2020.7589. JAMA Oncol. 2021. PMID: 33538782 Free PMC article. Clinical Trial.

2

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group.

Goldenberg SL, Klotz LH, Srigley J, Jewett MA, Mador D, Fradet Y, Barkin J, Chin J, Paquin JM, Bullock MJ, Laplante S. Goldenberg SL, et al. Among authors: chin j. J Urol. 1996 Sep;156(3):873-7. J Urol. 1996. PMID: 8709351 Clinical Trial.

3

CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group.

Klotz LH, Goldenberg SL, Jewett M, Barkin J, Chetner M, Fradet Y, Chin J, Laplante S. Klotz LH, et al. Among authors: chin j. Urology. 1999 Apr;53(4):757-63. doi: 10.1016/s0090-4295(98)00616-5. Urology. 1999. PMID: 10197852 Clinical Trial.

4

A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy.

Klotz L, Heaton J, Jewett M, Chin J, Fleshner N, Goldenberg L, Gleave M. Klotz L, et al. Among authors: chin j. J Urol. 2000 Nov;164(5):1573-8. J Urol. 2000. PMID: 11025707 Clinical Trial.

5

Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects.

Gleave ME, Goldenberg SL, Chin JL, Warner J, Saad F, Klotz LH, Jewett M, Kassabian V, Chetner M, Dupont C, Van Rensselaer S; Canadian Uro-Oncology Group. Gleave ME, et al. Among authors: chin jl. J Urol. 2001 Aug;166(2):500-6; discussion 506-7. J Urol. 2001. PMID: 11458055 Clinical Trial.

6

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy.

Klotz LH, Goldenberg SL, Jewett MA, Fradet Y, Nam R, Barkin J, Chin J, Chatterjee S; Canadian Uro-Oncology Group. Klotz LH, et al. Among authors: chin j. J Urol. 2003 Sep;170(3):791-4. doi: 10.1097/01.ju.0000081404.98273.fd. J Urol. 2003. PMID: 12913699 Clinical Trial.

7

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

Thompson IM Jr, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED. Thompson IM Jr, et al. Among authors: chin j. JAMA. 2006 Nov 15;296(19):2329-35. doi: 10.1001/jama.296.19.2329. JAMA. 2006. PMID: 17105795 Clinical Trial.

8

Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide.

Haider MA, Davidson SR, Kale AV, Weersink RA, Evans AJ, Toi A, Gertner MR, Bogaards A, Wilson BC, Chin JL, Elhilali M, Trachtenberg J. Haider MA, et al. Among authors: chin jl. Radiology. 2007 Jul;244(1):196-204. doi: 10.1148/radiol.2441060398. Epub 2007 May 16. Radiology. 2007. PMID: 17507719

9

Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses.

Trachtenberg J, Weersink RA, Davidson SR, Haider MA, Bogaards A, Gertner MR, Evans A, Scherz A, Savard J, Chin JL, Wilson BC, Elhilali M. Trachtenberg J, et al. Among authors: chin jl. BJU Int. 2008 Aug 5;102(5):556-62. doi: 10.1111/j.1464-410X.2008.07753.x. Epub 2008 May 20. BJU Int. 2008. PMID: 18494829 Clinical Trial.

10

Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.

Chi KN, Chin JL, Winquist E, Klotz L, Saad F, Gleave ME. Chi KN, et al. J Urol. 2008 Aug;180(2):565-70; discussion 570. doi: 10.1016/j.juro.2008.04.012. Epub 2008 Jun 12. J Urol. 2008. PMID: 18554663 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,136 results

Search Page